Kawasaki disease is a febrile disease of children complicated with vasculit
is of the coronary arteries and potential aneurysm formation. It has been r
ecognized worldwide and appears to be increasing in frequency. Studies have
found that Kawasaki disease is associated with major histocompatibility co
mplex (MHC) class I B antigens. The MHC-class-I-chain-related gene A (MICA)
is located near HLA-B. It has a triplet repeat microsatellite polymorphism
in the transmembrane region. We investigated the microsatellite polymorphi
sm in children with Kawasaki disease and controls. Seventy children (46 boy
s), age at diagnosis 1.68 +/- 1.69 years, with Kawasaki who were treated wi
th aspirin as well as intravenous gamma-globulin were enrolled. Control sub
jects consisted of 154 children (87 boys), age 2.81 +/- 2.12 years. Phenoty
pe frequency of allele A4 in patients with aneurysm formation was significa
ntly lower than in patients without aneurysms [relative risk (RR) = 0.06, 9
5% confidence interval (CI) = 0.01-0.48, p = 0.00469, pc = 0.0232] and show
ed a similar tendency when compared with controls. Gene frequency of allele
A4 was also significantly lower in patients who developed aneurysms than i
n patients who did not (RR = 0.07, 95% CI = 0.01-0.57, p = 0.0057, pc = 0.0
282). Gene frequency of allele A5 showed a tendency to be higher in patient
s who developed aneurysms than in controls (RR = 2.35, 95% CI = 0.98-5.63,
p = 0.0486, pc = 0.220). Allele A5.1 tended to be negatively associated wit
h Kawasaki disease (RR = 0.57, 95% CI = 0.35-0.93, p = 0.022, pc = 0.105).
Our study showed that allele A4 was negatively associated with coronary ane
urysm formation in Kawasaki disease. This suggests that allele A4 protects
the children with Kawasaki disease from developing coronary aneurysms after
aspirin and gamma globulin therapy. Copyright (C) 2000 S. Karger AG,Basel.